UTHR FY 2011 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$743M+23.1% YoY

Gross Profit

$654M88.0% margin

Operating Income

$318M42.8% margin

Net Income

$218M29.3% margin

EPS (Diluted)

$3.67

Cash Flow

Operating Cash Flow

$250M

Free Cash Flow

$214M

Stock-Based Comp.

-$16M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$570M

Stockholders' Equity

$948M

Cash & Equivalents

$163M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$743M	$604M	+23.1%
Gross Profit	$654M	$530M	+23.4%
Operating Income	$318M	$164M	+93.8%
Net Income	$218M	$106M	+105.7%